FDA Inspection 1196505 — UCSF Center For Reproductive Health
The FDA completed an inspection of UCSF Center For Reproductive Health on Jan 24, 2023 in San Francisco, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 24, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- San Francisco, CA (United States)